Archive for the 'Illness & Diseases' Category
Barbara Stephens, Chief Executive of for dementia, the charity responsible for Admiral Nurses says: “Dementia is a complex condition with many and varied causes. There needs to be a comprehensive and co-ordinated response to address this major public health issue.
More: continued here
Anavex Life Sciences Corp. (”ANAVEX”) (OTCBB: AVXL), a biopharmaceutical company engaged in the discovery and development of novel therapeutics to treat Central Nervous System (CNS) diseases and cancer, announces that the anti-amnesic and neuroprotective effects of ANAVEX 1-41 are detailed in a paper published in the current edition of Neuropsychopharmacology. Currently in the late pre-clinical stage, ANAVEX 1-41 is one of the company’s lead compounds for Alzheimer’s disease (AD).
More: continued here
The Council of European Health Ministers adopted far-reaching conclusions on public health strategies to combat neurodegenerative diseases associated with ageing and in particular Alzheimer’s disease on 16 December 2008.
More: continued here
Family and friends of a 75-year-old California grandmother beaten and kidnapped from her home last week might have known of the crime within moments if a device patented by an Indiana University researcher had been in use. If Sandy Vinge had been using The Portal Monitor developed by Indiana University professor L.
More: continued here
Adding another reason for people to watch their blood pressure, a new study from North Carolina State University shows that increased blood pressure in older adults is directly related to decreased cognitive functioning, particularly among seniors with already high blood pressure. This means that stressful situations may make it more difficult for some seniors to think clearly. Dr.
More: continued here
Very few species spontaneously develop the cognitive, behavioral and neuropathological symptoms of Alzheimer’s disease (AD), yet AD research must progress at a more rapid pace than the rate of human aging. Therefore, in recent years, a variety of animal models have been created - from tiny invertebrates with life spans measurable in months to huge mammals that live several decades.
More: continued here
Australian scientists at CSIRO (Commonwealth Scientific and Industrial Research Organisation), have developed a new system to screen for compounds that can inhibit one of the processes that takes place during the progression of Alzheimer’s disease. In a paper published in the November issue of the Journal of Alzheimer’s Disease, folate is shown to be beneficial in the screening system.
More: continued here
There are 700,000 people in the UK currently living with dementia. This number is expected to double by 2019, with 163,000 new cases of dementia occurring in England and Wales each year. In total, 42% of the UK population are affected by dementia - by way of knowing a close friend or family member with the condition.
More: continued here
The Roskamp Institute announced that its researchers have uncovered a new link between inflammation and Alzheimer’s disease and have identified a potential target for developing novel therapeutics for intervention in this disease. The study, led by Roskamp Institute’s Pancham Bakshi, Ph.D., is detailed in the American Chemical Society’s Chemical Biology Journal, a leading online publisher of peer-reviewed research.
More: continued here
People aged 65-plus are expected to make up almost a quarter of the UK population by 2032, the Office for National Statistics (ONS) said today. There were 9.5 million over-65s in the UK in 2007 compared with 8.5 million in 1982, a rise of 16%. The figure is projected to rise to 16.1 million by 2032, 23% of the estimated 71 million population. Age is the biggest risk factor for dementia. One in three people over the age of 65 die with this devastating condition.
More: continued here





